Market research

Small Animal Imaging

Explore licenses

360iResearch introduction

Small Animal Imaging: Executive Summary

Small animal imaging supports veterinary diagnosis, treatment planning, monitoring, and research across companion-animal and laboratory settings. The field brings together radiography, ultrasound, computed tomography, magnetic resonance imaging, endoscopy, and related image-management capabilities. Demand is shaped by rising expectations for evidence-based veterinary care, wider availability of advanced clinical services, and the need for efficient, reproducible imaging workflows.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Component

    • Equipment
    • Reagents & Consumables
    • Software
    • Services
    View chapter
  2. Chapter 8 Modality

    • Computed Tomography
    • Magnetic Resonance Imaging
    • Optical Imaging
    • Nuclear Imaging
    More in this chapter
  3. Chapter 9 Animal Type

    • Rodents
    • Rabbits
    • Zebrafish
    • Zebrafish
    View chapter

Clinical Integration Is Reshaping Small Animal Imaging

The landscape is shifting from standalone image acquisition toward integrated diagnostic pathways. Multimodal imaging, image archiving, teleradiology, structured reporting, and interoperability with practice-management systems are becoming increasingly important to workflow quality. Portable systems and point-of-care imaging are expanding access, while referral centers continue to require advanced modalities for complex neurological, orthopedic, oncological, and cardiovascular cases. Training, maintenance, radiation safety, and dependable service support remain essential to realizing clinical value.

Artificial Intelligence Is Accelerating Interpretation and Workflow Support

Artificial intelligence is influencing small animal imaging through image triage, anomaly detection, segmentation, measurement, protocol support, and quality control. Its most immediate contribution is workflow assistance: prioritizing studies, reducing repetitive tasks, and helping clinicians compare findings consistently. Effective adoption depends on representative veterinary datasets, transparent validation, integration with existing systems, human oversight, and safeguards against automation bias. AI is therefore best positioned as an augmentative capability rather than a substitute for veterinary expertise.

Regional Insights: Uneven Access Meets Broad Clinical Demand

North America combines strong specialty-care infrastructure with active adoption of advanced imaging and digital workflows. Europe benefits from established veterinary education and referral networks, although regulatory and reimbursement conditions vary across countries. Asia-Pacific presents diverse development levels, with expanding urban companion-animal services alongside significant demand for portable and cost-conscious systems. Latin America is characterized by growing private veterinary activity but uneven access to specialist equipment and trained personnel. The Middle East is developing advanced veterinary capacity in selected urban and institutional settings, while Africa shows a pronounced contrast between better-equipped centers and regions where basic diagnostic access, maintenance, and specialist training remain constrained.

Group Insights: Regulation, Trade, and Care Capacity Shape Adoption

ASEAN reflects varied veterinary infrastructure and a strong need for scalable, interoperable solutions. BRICS countries span substantial differences in clinical capacity, research ecosystems, regulation, and local manufacturing potential. The European Union is influenced by shared regulatory frameworks alongside national differences in education, reimbursement, and service delivery. G7 markets generally have mature specialty-care networks and greater readiness for data-enabled workflows. GCC countries are strengthening advanced healthcare and veterinary capabilities, particularly in major urban centers. NATO members represent diverse veterinary systems, but collaboration, procurement requirements, and institutional research needs can affect technology deployment.

Country Insights: Diverse Veterinary Systems Require Localized Strategies

Australia and Canada face geographically dispersed service needs, increasing the value of mobile imaging, remote interpretation, and reliable technical support. The United States combines extensive specialty-care capacity with sophisticated digital integration. Brazil, Mexico, and India contain large and diverse veterinary markets in which affordability, workforce development, and urban–rural access are central considerations. China, Japan, and South Korea show strong interest in technology-enabled clinical services, with adoption shaped by domestic regulation, hospital infrastructure, and specialist availability. France, Germany, Italy, Spain, and the United Kingdom benefit from established veterinary education and referral systems, while procurement, compliance, reimbursement, and regional service differences continue to influence implementation. Russia’s adoption environment is shaped by institutional capacity, import conditions, and access to technical support.

Action Priorities for Leaders in Small Animal Imaging

Leaders should align modality selection with clinical pathways, case volume, staffing, and total ownership requirements rather than pursuing technology in isolation. Priorities include interoperable data systems, validated protocols, cybersecurity, service contracts, radiation governance, and continuous workforce training. Organizations should introduce AI through narrowly defined, clinically supervised use cases with documented performance monitoring. Partnerships with referral networks, universities, and tele-imaging providers can extend specialist access. In less-served settings, rugged portable platforms, financing flexibility, local engineering support, and tiered training may deliver greater practical value than highly complex systems without dependable implementation capacity.

Research Methodology: Evidence-Based Market Assessment

This executive summary uses a structured review of the small animal imaging domain, focusing on modality adoption, clinical workflows, digital integration, AI applications, regional conditions, and institutional requirements. Findings are organized through comparative analysis of veterinary-care infrastructure, technology readiness, regulatory context, specialist availability, and access constraints across the specified regions, groups, and countries. Interpretations are limited to qualitative, data-backed themes and avoid unsupported estimates, forecasts, company attribution, and market-share claims.

Conclusion: Accessible, Integrated Imaging Will Define Progress

Small animal imaging is advancing toward connected, workflow-centered care in which diagnostic quality, accessibility, and operational reliability are considered together. The strongest opportunities are likely to arise where advanced modalities, portable solutions, remote expertise, and carefully governed AI address clear clinical needs. Sustainable progress will depend on localized implementation, validated technology, skilled personnel, interoperable infrastructure, and continued attention to safety, affordability, and equitable access.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Small Animal Imaging Market, by Component
    1. 7.1Introduction
    2. 7.2Equipment
    3. 7.3Reagents & Consumables
    4. 7.4Software
    5. 7.5Services
      1. 7.5.1Imaging Services
      2. 7.5.2Maintenance & Support
      3. 7.5.3Training Services
  8. 8.Small Animal Imaging Market, by Modality
    1. 8.1Introduction
    2. 8.2Computed Tomography
    3. 8.3Magnetic Resonance Imaging
    4. 8.4Optical Imaging
      1. 8.4.1Bioluminescence Imaging
      2. 8.4.2Fluorescence Imaging
      3. 8.4.3Cerenkov Luminescence Imaging
    5. 8.5Nuclear Imaging
    6. 8.6Ultrasound Imaging
  9. 9.Small Animal Imaging Market, by Animal Type
    1. 9.1Introduction
    2. 9.2Rodents
      1. 9.2.1Mice
      2. 9.2.2Rats
    3. 9.3Rabbits
    4. 9.4Zebrafish
    5. 9.5Zebrafish
  10. 10.Small Animal Imaging Market, by Automation Level
    1. 10.1Introduction
    2. 10.2Manual Systems
    3. 10.3Semi-Automated Systems
    4. 10.4Fully Automated Systems
  11. 11.Small Animal Imaging Market, by Application
    1. 11.1Introduction
    2. 11.2Cardiology
    3. 11.3Drug Discovery & Development
      1. 11.3.1Pharmacokinetics
      2. 11.3.2Pharmacodynamics
    4. 11.4Neurology
      1. 11.4.1Brain Mapping
      2. 11.4.2Neurodegenerative Disease Studies
    5. 11.5Oncology
      1. 11.5.1Tumor Detection
      2. 11.5.2Tumor Progression Monitoring
    6. 11.6Inflammation & Immunology
  12. 12.Small Animal Imaging Market, by End User
    1. 12.1Introduction
    2. 12.2Academic & Research Institutes
    3. 12.3Contract Research Organizations
    4. 12.4Hospitals & Clinics
    5. 12.5Pharmaceutical & Biotechnology Companies
  13. 13.Small Animal Imaging Market, by Region
    1. 13.1Introduction
    2. 13.2Asia-Pacific
    3. 13.3North America
    4. 13.4Latin America
    5. 13.5Europe
    6. 13.6Middle East
    7. 13.7Africa
  14. 14.Small Animal Imaging Market, by Group
    1. 14.1Introduction
    2. 14.2ASEAN
    3. 14.3GCC
    4. 14.4European Union
    5. 14.5BRICS
    6. 14.6G7
    7. 14.7NATO
  15. 15.Small Animal Imaging Market, by Country
    1. 15.1Introduction
    2. 15.2United States
    3. 15.3Canada
    4. 15.4Mexico
    5. 15.5Brazil
    6. 15.6United Kingdom
    7. 15.7Germany
    8. 15.8France
    9. 15.9Russia
    10. 15.10Italy
    11. 15.11Spain
    12. 15.12China
    13. 15.13India
    14. 15.14Japan
    15. 15.15Australia
    16. 15.16South Korea
  16. 16.Competitive Landscape
    1. 16.1Market Share Analysis, 2025
    2. 16.2Market Concentration Analysis, 2025
      1. 16.2.1Concentration Ratio (CR)
      2. 16.2.2Herfindahl Hirschman Index (HHI)
    3. 16.3Recent Developments & Impact Analysis, 2025
    4. 16.4Product Portfolio Analysis, 2025
    5. 16.5Benchmarking Analysis, 2025
  17. 17.Company Profiles
    1. 17.1Advanced Molecular Vision, Inc.
    2. 17.2Aspect Imaging Ltd.
    3. 17.3Berthold Technologies GmbH & Co. KG
    4. 17.4Bruker Corporation
    5. 17.5Cubresa Inc.
    6. 17.6FUJIFILM VisualSonics, Inc.
    7. 17.7General Electric Company
    8. 17.8IVIM Technology, Inc.
    9. 17.9LI-COR Biosciences, Inc.
    10. 17.10Medikors Inc.
    11. 17.11Mediso Ltd.
    12. 17.12MR Solutions Ltd.
    13. 17.13Optiscan Imaging Ltd
    14. 17.14Revvity, Inc.
    15. 17.15Rigaku Corporation
    16. 17.16Scanco Medical AG
    17. 17.17Sedecal S.A.
    18. 17.18Siemens Healthineers AG
    19. 17.19Thermo Fisher Scientific Inc.
    20. 17.20TriFoil Imaging, Inc.
    21. 17.21Vieworks Co., Ltd.
  18. 18.Key Experts

Loading the sample request form…